News Release

Rohto Pharmaceutical has published the "ROHTO Well-being Report - Integrated Report 2026".

Announcement Regarding the Acquisition of OP Biofactory as a Subsidiary

Supporting the establishment of the "General Incorporated Association for the Study of Ectopic Fat."

Azelaic acid is now available in a serum that makes it easy to incorporate into your daily skincare routine. "AZA Clear® Serum" is now available from the medical institution-exclusive brand "DRX®".

Rohto Pharmaceutical's "Mokatsu® Project" is participating.

Rohto Pharmaceutical and E-derm have entered into an agreement regarding exclusive evaluation and licensing options.

support for entrepreneurs within the company program, "Asuniwa project" won a Special Jury Prize at the "Bizcon AWARDS 2026."

Announcement Regarding the Acquisition of Shares (Making it a Subsidiary) of Magic Cod doo, a Cosmetics Distributor in the Republic of Serbia

Rohto Pharmaceutical and Osaka Prefecture are jointly organizing Feminine Care seminar for mothers and daughters titled "Understanding Women's Bodies and Self-Care Correctly as a Mother and Daughter."

Rohto Pharmaceutical and Eu Yan Sang Skincare have collaborated for the first time. New products will be released from the medical institution-exclusive brand "Dermacept RX Stem Advance®".